https://www.selleckchem.com/products/ho-3867.html
It fitted well with actual incidence of relapse. The serial MRD data collected after alloHSCT had better discrimination capabilities for recurrence prediction with the area under the curve from 0.67 to 0.91 (AML 0.66-0.89; ALL 0.70-0.96). The joint model was able to dynamically predict relapse-free probability after alloHSCT, which would be a useful tool to provide important information to guide decision-making in the clinic and facilitate the individualized therapy. The joint model was able to dynamically predict relapse-free probabili